304 related articles for article (PubMed ID: 31917799)
21. Sex and APOE Genotype Alter the Basal and Induced Inflammatory States of Primary Astrocytes from Humanized Targeted Replacement Mice.
Mhatre-Winters I; Eid A; Han Y; Tieu K; Richardson JR
ASN Neuro; 2023; 15():17590914221144549. PubMed ID: 36604975
[TBL] [Abstract][Full Text] [Related]
22. Obesity affects brain cortex gene expression in an APOE genotype and sex dependent manner.
Pandit H; Jones NS; Rebeck GW
Int J Obes (Lond); 2024 Jun; 48(6):841-848. PubMed ID: 38454009
[TBL] [Abstract][Full Text] [Related]
23. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
24. APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.
Toledo JB; Habes M; Sotiras A; Bjerke M; Fan Y; Weiner MW; Shaw LM; Davatzikos C; Trojanowski JQ;
J Alzheimers Dis; 2019; 69(3):783-793. PubMed ID: 31127775
[TBL] [Abstract][Full Text] [Related]
25. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
[TBL] [Abstract][Full Text] [Related]
26. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
27. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
[TBL] [Abstract][Full Text] [Related]
28. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
[TBL] [Abstract][Full Text] [Related]
29. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
[TBL] [Abstract][Full Text] [Related]
30. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
31. Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer's disease.
Chang R; Trushina E; Zhu K; Zaidi SSA; Lau BM; Kueider-Paisley A; Moein S; He Q; Alamprese ML; Vagnerova B; Tang A; Vijayan R; Liu Y; Saykin AJ; Brinton RD; Kaddurah-Daouk R;
Alzheimers Dement; 2023 Feb; 19(2):518-531. PubMed ID: 35481667
[TBL] [Abstract][Full Text] [Related]
32. Effects of sex and APOE ε4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy study.
Jett S; Dyke JP; Boneu Yepez C; Zarate C; Carlton C; Schelbaum E; Jang G; Pahlajani S; Williams S; Diaz Brinton R; Mosconi L
PLoS One; 2023; 18(2):e0281302. PubMed ID: 36787293
[TBL] [Abstract][Full Text] [Related]
33. APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains.
Ojo JO; Reed JM; Crynen G; Vallabhaneni P; Evans J; Shackleton B; Eisenbaum M; Ringland C; Edsell A; Mullan M; Crawford F; Bachmeier C
Mol Brain; 2021 Jul; 14(1):110. PubMed ID: 34238312
[TBL] [Abstract][Full Text] [Related]
34. APOE genotype and biological sex regulate astroglial interactions with amyloid plaques in Alzheimer's disease mice.
Stephen TL; Breningstall B; Suresh S; McGill CJ; Pike CJ
J Neuroinflammation; 2022 Dec; 19(1):286. PubMed ID: 36457019
[TBL] [Abstract][Full Text] [Related]
35. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide.
Hashimoto T; Serrano-Pozo A; Hori Y; Adams KW; Takeda S; Banerji AO; Mitani A; Joyner D; Thyssen DH; Bacskai BJ; Frosch MP; Spires-Jones TL; Finn MB; Holtzman DM; Hyman BT
J Neurosci; 2012 Oct; 32(43):15181-92. PubMed ID: 23100439
[TBL] [Abstract][Full Text] [Related]
37. APOΕ4 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis.
Farmer BC; Williams HC; Devanney NA; Piron MA; Nation GK; Carter DJ; Walsh AE; Khanal R; Young LEA; Kluemper JC; Hernandez G; Allenger EJ; Mooney R; Golden LR; Smith CT; Brandon JA; Gupta VA; Kern PA; Gentry MS; Morganti JM; Sun RC; Johnson LA
Mol Neurodegener; 2021 Sep; 16(1):62. PubMed ID: 34488832
[TBL] [Abstract][Full Text] [Related]
38. Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology.
Koren-Iton A; Salomon-Zimri S; Smolar A; Shavit-Stein E; Dori A; Chapman J; Michaelson DM
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075060
[TBL] [Abstract][Full Text] [Related]
39. Human ApoE ɛ2 Promotes Regulatory Mechanisms of Bioenergetic and Synaptic Function in Female Brain: A Focus on V-type H+-ATPase.
Woody SK; Zhou H; Ibrahimi S; Dong Y; Zhao L
J Alzheimers Dis; 2016 Jun; 53(3):1015-31. PubMed ID: 27340853
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.
Lewandowski CT; Maldonado Weng J; LaDu MJ
Neurobiol Dis; 2020 Jun; 139():104811. PubMed ID: 32087290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
